Multiparameter disease diagnostics: Chemical challenges and analytical opportunities

Ryan C. Bailey

Research output: Contribution to conferencePaper

Abstract

The promise of personalized disease diagnostics is currently limited by the analytical ability to measure the required level of genomic and proteomic detail from accessible clinical samples. Among several challenges are the simultaneous cross-platform quantitation and correlation of gene and protein expression, and the development of robust, sensitive and scalable detection technologies. To meet these challenges many new technologies are currently being developed. Two such approaches will be discussed: the recently described DNA-encoded antibody library strategy, which also introduces integrated "on-chip" cell sorting, and multiplexed, label-free microring resonator-based biosensors.

Original languageEnglish (US)
Pages19-24
Number of pages6
StatePublished - Dec 1 2007
Event4th Conference on Foundations of Nanoscience: Self-Assembled Architectures and Devices, FNANO 2007 - Snowbird, UT, United States
Duration: Apr 18 2007Apr 21 2007

Other

Other4th Conference on Foundations of Nanoscience: Self-Assembled Architectures and Devices, FNANO 2007
CountryUnited States
CitySnowbird, UT
Period4/18/074/21/07

ASJC Scopus subject areas

  • Hardware and Architecture
  • Electrical and Electronic Engineering

Fingerprint Dive into the research topics of 'Multiparameter disease diagnostics: Chemical challenges and analytical opportunities'. Together they form a unique fingerprint.

  • Cite this

    Bailey, R. C. (2007). Multiparameter disease diagnostics: Chemical challenges and analytical opportunities. 19-24. Paper presented at 4th Conference on Foundations of Nanoscience: Self-Assembled Architectures and Devices, FNANO 2007, Snowbird, UT, United States.